Congress directs the FDA to “sample current CBD products for mislabeling & doctoring”
Congress through the 2020 federal spending bill directs the FDA to “sample current CBD products for mislabeling & doctoring”. This along with 4 other Marijuana, Hemp & CBD stipulations was added.